Skip to Content

Mesna Injection

Last Updated: February 5, 2016
Status: Resolved

Products Affected - Description

Mesna solution for injection, Mylan Institutional
100 mg/mL, 10 mL vial, 10 count (NDC 67457-0148-10)

Reason for the Shortage

  • Fresenius Kabi had mesna on shortage due to increased demand.
  • Mylan could not give a reason for the shortage of mesna.
  • Sagent had mesna on shortage due to manufacturing delays.
  • Teva had a shortage of mesna injection due to manufacturing delays.
  • West-Ward discontinued mesna injection in September 2014.

Available Products

Mesnex solution for injection, Baxter
100 mg/mL, 10 mL vial, 1 count (NDC 00338-1305-01)
100 mg/mL, 10 mL vial, 10 count (NDC 00338-1305-03)

 
Mesna injection, Baxter
100 mg/mL, 10 mL vial, 1 count (NDC 10019-0953-01)
100 mg/mL, 10 mL vial, 10 count (NDC 10019-0953-02)
 
Mesna solution for injection, Fresenius Kabi
100 mg/mL, 10 mL vial, 1 count (NDC 63323-0733-11)
100 mg/mL, 10 mL vial, 10 count (NDC 63323-0733-10) 
 
Mesna injection, Sagent
100 mg/mL, 10 mL vials, 1 count (NDC 25021-0201-10)
100 mg/mL, 10 mL vial, 10 count (NDC 25021-0201-11)
 
Mesna injection, Teva
100 mg/mL, 10 mL vial, 10 count (NDC 00703-4805-03)

Estimated Resupply Dates

  • Mylan Institutional has mesna 10 mL vials on back order and the company cannot estimate a release date.
  • All other marketed suppliers have product available.

Related Shortages

Updated

February 5, 2016; December 9, October 29, September 3, August 13, July 8, May 18, April 9, March 13, February 23, 18 and 2, January 16 and 9, 2015; December 12, 2014, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide